HIGHLIGHTS
Increases in all sales related KPI’s across the business for the quarter ended 30 September 2020:
• $750K revenue recognized during the quarter out of the $1.25M received in June 2020 in relation to the second quarterly license milestone as per the government funded licenses grant.
• 795 Residential Aged Care (RAC) Facilities and 66,887 approved beds are under annual PainChek® license as at 30 September 2020, representing a 10% and 9% increase respectively over the previous quarter and 397% and 457% growth over the previous year.
• Total beds under license as at 30 September 2020 equates to $2.79M in normalized contracted Annualized Recurring Revenue (ARR) in Year 2 of the client contracts (post government funded licenses)representing 323% growth over previous year.
• There have now been more than 190,000 clinical pain assessments conducted by clients, a 41% growth in the quarter and 241% growth over the previous year, demonstrating the App’s strong clinical utility and uptake in the residential aged care market.
• Three pilots in the $2 Billion Australian Home Care market now underway with leading Australian Home Care providers to support the increasing demand for home care service and packages.
• New Hospital research commercial agreement in place with Ramsey Hospital Research and Cowan University for frail patient pain management.
• New Disability commercial agreement with Nulsen Group, opening access to the large NDIS market.
• Canada regulatory clearance pending and commercial partnership now in place with AlayaCare, the leading Home Care software care management system provider in Canada.
• Positive progress in revised Children’s App clinical study – targeting 2021 TGA and CE Mark clearance.
• Pre-submission supplement application with FDA completed.
• The Company raised $10M in August 2020 via a private placement with professional and sophisticated investors at $0.11 per share. The funds will be used to accelerate international growth opportunities and to develop new products.
• As a result of the capital raising, PainChek’s consolidated cash balance at 30 September 2020 increasedto $13.8M
- Forums
- ASX - By Stock
- PCK
- Ann: September 2020 Quarterly Update
Ann: September 2020 Quarterly Update, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
|
|||||
Last
3.0¢ |
Change
0.001(3.45%) |
Mkt cap ! $47.43M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 3.0¢ | $1.51K | 50.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 86795 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 471 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 104367 | 0.030 |
1 | 400000 | 0.029 |
5 | 1843573 | 0.028 |
10 | 1559179 | 0.027 |
4 | 674000 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 471 | 1 |
0.032 | 254901 | 3 |
0.033 | 440208 | 4 |
0.034 | 5874 | 1 |
0.035 | 40000 | 1 |
Last trade - 12.56pm 10/07/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online